↓ Skip to main content

Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study

Overview of attention for article published in Cephalalgia, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
policy
3 policy sources
patent
2 patents

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
84 Mendeley